Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-3-20
|
pubmed:abstractText |
The study reported here was undertaken to determine the nephrotoxicosis associated with the administration of cisplatin, an antineoplastic agent, to dogs when administered during 6-hour saline solution diuresis. Cisplatin (70 mg/m2 of body surface, IV, every 21 days) was given to 61 dogs with malignant neoplasia with a total of 185 doses in 1 (n = 9 dogs), 2 (n = 26 dogs), 3 (n = 4 dogs), 4 (n = 9 dogs), 5 (n = 2 dogs), and 6 (n = 11 dogs) treatments. The cisplatin was given over a 20-minute period after 0.9% NaCl solution (saline solution) was administered IV for 4 hours at a rate of 18.3 ml/kg of body weight/h. After the cisplatin infusion, saline solution diuresis was continued at the same rate for 2 hours. Before each treatment with cisplatin, dogs were evaluated with at least a physical examination, CBC, determination of serum urea nitrogen concentration, and in most cases, determination of serum creatinine concentration and urine specific gravity. Four of the 61 dogs (6.6%) developed clinically evident renal disease after 2 (1 dog), 3 (2 dogs), and 4 (1 dog) doses of cisplatin were administered. Three of the 4 dogs had preexisting disease of the urinary tract prior to the start of treatment. The survival time in dogs that developed renal disease (median, 145 days; range, 15 to 150 days) was similar to that of all dogs in this study (median, 154 days; range, 30 to 500 days), with 13 dogs still alive at the conclusion of the study.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-1488
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
199
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
613-6
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1787122-Animals,
pubmed-meshheading:1787122-Blood Urea Nitrogen,
pubmed-meshheading:1787122-Cisplatin,
pubmed-meshheading:1787122-Creatinine,
pubmed-meshheading:1787122-Diuresis,
pubmed-meshheading:1787122-Dog Diseases,
pubmed-meshheading:1787122-Dogs,
pubmed-meshheading:1787122-Female,
pubmed-meshheading:1787122-Kidney,
pubmed-meshheading:1787122-Kidney Diseases,
pubmed-meshheading:1787122-Male,
pubmed-meshheading:1787122-Neoplasms,
pubmed-meshheading:1787122-Prevalence,
pubmed-meshheading:1787122-Retrospective Studies,
pubmed-meshheading:1787122-Specific Gravity,
pubmed-meshheading:1787122-Urine
|
pubmed:year |
1991
|
pubmed:articleTitle |
Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).
|
pubmed:affiliation |
Department of Clinical Sciences, College of Veterinary Medicine, Colorado State University, Fort Collins 80523.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|